Drug Profile
Collagen/bone growth factor - Centerpulse
Alternative Names: Ne-OsteoLatest Information Update: 16 Oct 2003
Price :
$50
*
At a glance
- Originator Centerpulse
- Developer Centerpulse; Centerpulse Orthopedics; Centerpulse Spine-Tech
- Class Biopolymers
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bone disorders; Periodontal disorders
Most Recent Events
- 16 Oct 2003 Centerpulse has been acquired by Zimmer Holdings
- 21 Oct 2002 Sulzer Orthopedics is now called Centerpulse Orthopedics
- 21 Oct 2002 Sulzer Spine-Tech is now called Centerpulse Spine-Tech